Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.
about
Recent developments in adenosine receptor ligands and their potential as novel drugs2-Dialkynyl derivatives of (N)-methanocarba nucleosides: 'Clickable' A(3) adenosine receptor-selective agonists.Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptorPredicted structures of agonist and antagonist bound complexes of adenosine A3 receptorFunctionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactionsStructure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists.Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3-d]pyrimidine derivatives.Exploring the Role of N6-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice ∇.Discovery of benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies.
P2860
Q27687253-40EEE316-92DC-43CE-8989-928B260E7A34Q33638882-4A19CD5B-6C64-4DFF-952F-DC2167B4E31CQ33894529-714F9B88-99A7-48F5-8B0C-EDC4CD179BBBQ34975607-7C56EEA5-3CF7-4CA2-B865-EF5BE88B21FFQ35029175-AF418C53-E6DD-46D3-970E-98B7396DCE1CQ35987700-F3DB77A5-CF34-4C38-AA6D-1FE7CB231C97Q37062531-ACF7D9A6-BD63-48F3-A48F-FCC0120C1FDBQ37598464-DC5C6AD1-F7E9-497C-A2CF-44D67686A195Q39418010-CED8967F-A8BD-4D47-93E0-1B8B8BB8688BQ46475985-B8E19594-069C-40D1-AA62-742BE25721ABQ47384028-B5EE0FB0-1E0B-4ACE-9C30-0FA190952D6DQ48226209-E2787A1E-F12C-4DDA-89EF-827B14F65DFFQ52668077-2BA9DBD3-68E3-48C2-8DE0-00D26DFD7945
P2860
Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@ast
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@en
type
label
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@ast
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@en
prefLabel
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@ast
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@en
P2093
P2860
P50
P1476
Medicinal chemistry of the A3 ...... sts, and receptor engineering.
@en
P2093
Andrei A Ivanov
Athena M Klutz
Pier Giovanni Baraldi
P2860
P304
P356
10.1007/978-3-540-89615-9_5
P577
2009-01-01T00:00:00Z